Literature DB >> 12774843

Localization of corticoliberin receptors in the rat brain.

E A Rybnikova1, M Pelto-Huikko, V V Rakitskaya, V G Shalyapina.   

Abstract

In situ hybridization was used to study the distribution of corticoliberin receptors of subtypes 1 and 2 (CL-R1 and CL-R2 respectively) in different structures of the rat brain. Levels of CL-R1 mRNA in the brain were significantly greater than levels of CL-R2 mRNA, and the most intense expression of the CL-R1 gene was seen in forebrain structures, especially various neocortical, archicortical, and paleocortical regions in the cerebellar cortex. In addition, significant levels of CL-R1 mRNA expression were noted in the red nucleus and the reticular nucleus of the tegmentum. Intense expression of CL-R2 mRNA was observed in structures of the olfactory system, corticomedial parts of the amygdala, fields CA1-CA4 of the hippocampus, the ventromedial hypothalamus, and several brain stem nuclei. Moderate levels of CL-R2 mRNA were seen in the dorsolateral neostriatum. These results provide evidence that corticoliberin receptors of both subtypes are widespread in the brain. The different patterns of expression of CL-R1 and CL-R2 in the brain probably provide the basis for the functional specificity of action of corticoliberin in brain structures.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12774843     DOI: 10.1023/a:1022807926406

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  25 in total

1.  Expression cloning of a human corticotropin-releasing-factor receptor.

Authors:  R Chen; K A Lewis; M H Perrin; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

2.  Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.

Authors:  T W Lovenberg; C W Liaw; D E Grigoriadis; W Clevenger; D T Chalmers; E B De Souza; T Oltersdorf
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

3.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

Authors:  W Vale; J Spiess; C Rivier; J Rivier
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

Review 4.  [Corticoliberinergic mechanisms of the neostriatum in the neuroendocrine stress regulation].

Authors:  V G Shaliapina; E A Rybnikova; V V Rakitskaia
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  2000-11

5.  Central corticotropin-releasing factor administration prevents the excessive body weight gain of genetically obese (fa/fa) rats.

Authors:  F Rohner-Jeanrenaud; C D Walker; R Greco-Perotto; B Jeanrenaud
Journal:  Endocrinology       Date:  1989-02       Impact factor: 4.736

6.  [Early gene expression in the rat brain following administration of corticoliberin in the neostriatum].

Authors:  E A Rybnikova; M Pelto-Huikko; V G Shaliapina
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  2001-06

7.  Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression.

Authors:  D T Chalmers; T W Lovenberg; E B De Souza
Journal:  J Neurosci       Date:  1995-10       Impact factor: 6.167

Review 8.  Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders.

Authors:  E B De Souza
Journal:  Psychoneuroendocrinology       Date:  1995       Impact factor: 4.905

9.  Evidence for the involvement of corticotrophin-releasing hormone in the pathogenesis of traumatic brain injury.

Authors:  S Y Roe; E M McGowan; N J Rothwell
Journal:  Eur J Neurosci       Date:  1998-02       Impact factor: 3.386

10.  Regulation of corticotropin-releasing hormone receptor messenger ribonucleic acid in the rat brain and pituitary by glucocorticoids and stress.

Authors:  S Makino; J Schulkin; M A Smith; K Pacák; M Palkovits; P W Gold
Journal:  Endocrinology       Date:  1995-10       Impact factor: 4.736

View more
  3 in total

Review 1.  Evidence for the role of corticotropin-releasing factor in major depressive disorder.

Authors:  R Parrish Waters; Marion Rivalan; D A Bangasser; J M Deussing; M Ising; S K Wood; F Holsboer; Cliff H Summers
Journal:  Neurosci Biobehav Rev       Date:  2015-08-10       Impact factor: 8.989

2.  Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes.

Authors:  Lacey L Sahuque; Erika F Kullberg; Andrew J Mcgeehan; Jennifer R Kinder; Megan P Hicks; Mary G Blanton; Patricia H Janak; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2006-03-28       Impact factor: 4.530

3.  Angiotensin II AT1 receptor blocker candesartan prevents the fast up-regulation of cerebrocortical benzodiazepine-1 receptors induced by acute inflammatory and restraint stress.

Authors:  Enrique Sánchez-Lemus; Masaru Honda; Juan M Saavedra
Journal:  Behav Brain Res       Date:  2012-04-04       Impact factor: 3.332

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.